Echinacea species and alkamides inhibit prostaglandin E2 production in RAW264.7 mouse macrophage cells

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 18, 2007, Pages 7314-7322

  LaLone, Carlie A ^a   Hammer, Kimberly D P ^a   Wu, Lankun ^a   Bae, Jaehoon ^a   Leyva, Norma ^a,b   Liu, Yi ^a   Solco, Avery K S ^a   Kraus, George A ^a   Murphy, Patricia A ^a   Wurtele, Eve S ^a   Kim, Ok Kyung ^a,c   Seo II, Kwon ^a,d   Widrlechner, Mark P ^a,e   Birt, Diane F ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Department of Statistics Center for Statistics and Applications in Forensic Evidence Iowa State University 2438 Osborn Dr Ames   (United States)

^c Daejin University   (South Korea)

^d Sunchon National University   (South Korea)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Anti inflammatory; Cytotoxicity; Echinacea angustifolia; Echinacea pallida; Echinacea purpurea; Echinacea sanguinea; Echinacea simulata; Echinacea tennesseensis

Indexed keywords

ALKANE; AMIDE; ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PROSTAGLANDIN E2;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ECHINACEA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACROPHAGE; METABOLISM; MOUSE;

ALKANES; AMIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; ECHINACEA; MACROPHAGES; MICE; PLANT EXTRACTS;

ECHINACEA ANGUSTIFOLIA; ECHINACEA PALLIDA; ECHINACEA PURPUREA; ECHINACEA SANGUINEA; ECHINACEA SIMULATA; ECHINACEA TENNESSEENSIS;

EID: 34848854141     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf063711a     Document Type: Article

References (35)

1. Koenig, K.; Roehr, C. Does treatment with Echinacea purpurea effectively shorten the course of upper respiratory tract infections in children? Arch. Dis. Child. 2006, 91, 535-537.
2. Borchers, A.; Keen, C.; Stern, J.; Gershwin, M. Inflammation and Native American medicine: role of botanicals. Am. J. Clin. Nutr. 2000, 72, 339-347.
3. Harborne, J.; Williams, C. Phytochemistry of the genus Echinacea. In Echinacea The Genus Echinacea; Miller, S., Ed.; CRC Press: Boca Raton, FL, 2004; pp 39, 55-71.
4. Dalby-Brown, L.; Barsett, H.; Landbo, A.; Mayer, A.; Molgaard, P. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins. J. Agric. Food Chem. 2005, 53, 9413-9423.
5. Upton, R.; Graff, A.; Swisher, D.; McGuffin, M.; Pizzorno, J.; Prill, R. Echinacea pupurea Root: Echinacea purpurea (L.) Moench. Standards of Analysis, Quality Control, and Therapeutics. American Herbal Pharmacopoeia and Therapeutic Compendium; Scotts Valley, CA, 2004; pp 1-53.
6. Schoop, R.; Klein, P.; Suter, A.; Johnston, S. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin. Ther. 2006, 28, 174-183.
7. Schulten, B.; Bulitta, M.; Ballering-Bruhl, B.; Koster, U.; Schafer, M. Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomized, double-blind clinical trial. Arzneimittelforschung 2001, 51, 563-568.
8. Goel, V.; Lovlin, R.; Barton, R.; Lyon, M.; Bauer, R.; Lee, T.; Basu, T. Efficacy of a standardized Echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J. Clin. Pharm. Ther. 2004, 29, 75-83.
9. Sperber, S.; Shah, L.; Gilbert, R.; Ritchey, T.; Monto, A. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin. Infect. Dis, 2004, 38, 1367-1371.
10. Yale, S.; Liu, K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch. Intern. Med. 2004, 164, 1237-1241.
11. Binns, S.; Hudson, J.; Merali, S.; Amason, J. Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae: Asteraceae) against Herpes simplex virus (HSV-I). Planta Med. 2002, 68, 780-783.
12. Chen, Y.; Fu, T.; Tao, T.;. Yang, J.; Chang, Y.; Wang, M.; Kim, L.; Qu, L.; Cassady, J.; Scalzo, R.; Wang, X. Macrophage activating effects of new alkamides from the roots of Echinacea species. J. Nat. Prod. 2005, 68, 773-776.
13. 2 production by nitric oxide in activated murine macrophages. J. Immunol. 1999, 162, 4191-4197.
14. Bauer, R.; Jurcic, K.; Puhlmann, J.; Wagner, H. Immunological in vivo and in vitro examinations of Echinacea extracts. Arzneim. Forsch J Drug Res. 1988, 38, 276-281.
15. 2 production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264.7 mouse macrophage cells. J. Agric. Food Chem. 2007, 55, 7323-7331.
16. Schmitt, L.; Liu, Y.; Murphy, P.; Birt, D. Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds. J. Agric. Food Chem. 2006, 54, 2881-2890.
17. Wu, L.; Bae, J.; Kraus, G.; Wurtele, E. Diacetylenic isobutylamides of Echinacea: synthesis and natural distribution. Phytochemistry 2004, 65, 2477-2484.
18. Kraus, G.; Bae, J. Synthesis of N-(2-methylpropyl)-2E-undecene-8,10-diynamide, a novel constituent of Echinacea angustifolia. Tetrahedron Lett. 2003, 44, 5505-5506.
19. Bae, J. Synthesis of the natural compounds in Echinacea. Thesis, Iowa State University, 2006.
20. Bone, K. Echinacea: Quality, uses, and immunomodulating activity from a phytotherapist's perspective. In Echinacea The Genus Echinacea; Miller, S., Ed.; CRC Press: Boca Raton, FL, 2004; pp 39, 203-213.
21. Barnes, J.; Anderson, L.; Gibbons, S.; Phillipson, J. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 2005, 57, 929-954.
22. Aparecida Resende, F.; de Andrade Barcala, C.; da Silva Faria, M.; Kato, F.; Cunha, W.; Tavares, D. Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice. Life Sci. 2006, 79, 1268-1273.
23. Senchina, D.; Wu, L.; Flinn, G.; Konopka, D.; Widrelechner, M.; Wurtele, E.; Kohut, M. Year-and-a-half old, dried Echinaea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination. Planta Med. 2006, 72, 1207-1215.
24. Bauer, R.; Remiger, P. TLC and HPLC analysis of alkamides in Echinacea drugs. Planta Med. 1989, 55, 367-371.
25. Dunnett, C. W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 1955, 50, 1096-1121.
26. Yu, H.; Kaarlas, M. Popularity, diversity, and quality of Echinacea. In Echinacea The Genus Echinacea; Miller, S., Ed.; CRC Press: Boca Raton, FL, 2004; pp 39, 127-149.
27. Woelkart, K.; Xu, W.; Pei, Y.; Makriyannis, A.; Picone, R.; Bauer, R. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Med. 2005, 71, 701-705.
28. Raduner, S.; Majewska, A.; Chen, J.; Xie, X.; Hamon, J.; Faller, B.; Altmann, K.; Gertsch, J. Alkylamides from Echinacea are a new class of cannabinomimetics: cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J. Biol. Chem. 2006, 20, 14192-14206.
29. Gertsch, J.; Schoop, R.; Kuenzle. U.; Suter, A. Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 2004, 577, 563-569.
30. McGregor, R. The taxonomy of the genus Echinacea (Compositae). Univ. Kans. Sci. Bull. 1968, No. 48, 113-142.
31. Matthias, A.; Blanchfield, J.; Penman, K.; Toth, I.; Lang, C.; De Voss, J.; Lehmann, R. Permeability studies of alkylamides and caffeic acid conjugates from Echinacea using a Caco-2 cell monolayer model. J. Clin. Pharm. Ther. 2004, 29, 7-13.
32. Jager, H.; Meinel, L.; Dietz, B. Transport of alkamides from Echinacea species though Caco-2 monolayers. Planta Med. 2002, 68, 469-471.
33. Matthias, A.; Gillam, E.; Penman, K.; Matovic, N.; Bone, K.; De Voss, J.; Lehmann, R. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes. Chem. Biol. Interact. 2005, 165, 62-70.
34. Woelkart, K.; Koidl, C.; Grisold, A.; Gangemi, J.; Turner, R.; Marth, E.; Bauer, R. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans. J. Clin. Pharmacol. 2005, 45, 683-689.
35. Matthias, A.; Addison, R.; Penman, K.; Dickinson, R.; Bone, K.; Lehmann, R. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion. Life Sci. 2005, 77, 2018-2029.